Emicizumab,Abbexa,abx831353
Emicizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting F10/F9 activated form, for use in laboratory research applications. This product is not suitable for use as medicines or in Human, therapeutic or diagnostic applications.
Host
Mammalian cells
Reactivity
Human
Application
ELISA, WB
Conjugate
Unconjugated
Platform ID
BAB737551997
Abbexa
Contact
Tel: +44 (0) 1223 755950
Fax: +44 (0) 1223 755951
Email:
Product Specifications
Specifications
NameEmicizumab
Cat. No.abx831353
HostMammalian cells
IsotypeIgG4 Kappa
ReactivityHuman
ConjugationUnconjugated
ApplicationELISA, WB
Working DilutionsOptimal dilutions/concentrations should be determined by the end user.
ClonalityMonoclonal
Concentration4 mg/ml
TargetF10/F9 activated form
PurityPurified from cell culture supernatants by Protein A/G chromatography.
Appearance/FormLiquid
Formulation0.01 M PBS, pH 7.4.
StorageAliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Regulatory StatusResearch Use Only
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.